You are here: Industry Insights > Imperial College London

News List

Report finds almost 100% of people tested positive for antibodies after second vaccine dose pharmatimes
July 16, 2021
A new report from Imperial College London and Ipsos MORI has shown that almost 100% of people tested positive for antibodies 14 days after their second dose of the Pfizer/BioNTech or AstraZeneca COVID-19 vaccines.
New hope for long COVID blood tests after antibody discovery pharmatimes
July 14, 2021
A blood test for long COVID could be only six months away after researchers from Imperial College London discovered distinct antibodies in patients with persistent symptoms.
Modus Therapeutics partners with Imperial College London on malaria drug pharmatimes
June 16, 2021
Swedish biotech company Modus Therapeutics has announced a new collaboration with Imperial College London to research the effects of its drug sevuparin in patients with severe malaria.
Imperial COVID-19 vaccine begins human testing pharmatimes
June 30, 2020
Imperial College London's experimental COVID-19 vaccine has been given to the first healthy volunteer at a facility in West London.
UK funds human trials of Imperial College London’s COVID-19 vaccine research expresspharma
June 17, 2020
Robin Shattock, a professor at Imperial’s department of infectious disease, said that rather than using a part of the virus, as many vaccines do, this potential vaccine uses synthetic strands of the virus’ genetic material - RNA - which are packaged ....
Imperial College London partners with NHS Trust to make PPE pharmatimes
May 07, 2020
As of this morning – Thursday May 7 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 201,101 with 30,076 deaths.
Bayer partners with Imperial College London for AI drug discovery pharmaceutical-technology
December 21, 2018
Germany-based Bayer Pharmaceuticals has partnered with Imperial College London to leverage artificial intelligence (AI) to drive drug discovery for heart disorders....
Researchers eliminate mosquito population through CRISPR gene editing technology pharmafile
September 29, 2018
Researchers at Imperial College London have been able to wipe out a population of mosquitoes through ‘gene drive’ technology...